Table 2. Outcome data per study.
| Study,Year | Sample size (n/N) | Mortality (n/N) | Treatment duration (n/N) | Length of hospital stay, d (n/N) | Length of ICU stay, d (n/N) | Developed ARDS (n/N) | Required mechanical ventilation (n/N) | Hyperglycemia requiring treatment (n/N) | Gastrointestinal bleeding (n/N) |
|---|---|---|---|---|---|---|---|---|---|
| Marik, 1993 | 14/16 | 1/3 | ≤5d | - | 4.30±3.80/4.60±5.90 | - | 2/4 | - | - |
| Confalonieri, 2005 | 23/23 | 0/8 | >5d | 22.25±10.75/29.25±17.25 | 14.25±7.25/21.00±10.25 | 0/4 | - | - | 1/1 |
| El-Ghamray, 2006 | 17/17 | 3/6 | >5d | - | - | 0/3 | - | 1/1 | |
| Snijders, 2010 | 48/45 | 4/3 | >5d | - | - | - | - | - | |
| Sabry, 2011 | 40/40 | 2/6 | >5d | - | - | 2/6 | - | - | |
| Fernandez-Serrano, 2011 | 23/22 | 1/1 | >5d | 10.00±2.96/12±6.67 | 6.50±2.69/10.50±13.52 | - | 1/5 | 1/0 | 1/1 |
| Nafae, 2013 | 60/20 | 4/6 | >5d | 9.27±2.40/16.50±2.24 | 3.10±4.90/6.30±8.20 | - | 8/5 | 19/8 | 1/1 |
| Torres, 2015 | 61/59 | 6/9 | ≤5d | 11.00±4.81/10.50±5.19 | 5.00±3.70/6.00±2.96 | - | 5/9 | 11/7 | 0/1 |
ICU: intensive care unit; ARDS: acute respiratory distress syndrome; n: the number of patients in the corticosteroids group, N: the number of patients in the control group.